Search research articles
Contact Us
Filters
Showing results (251-260 of 289) with videos related to
Page
of 29
Sort By:
Cancers
|
March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface
Hassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 6, 2020
Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular Rejection
Elizabeth Cho, Joyce K Y Wu, Daniella Cunha Birriel, et al.
Molecular Oncology
|
May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
Belamy B Cheung, Owen Tan, Jessica Koach, et al.
Oncotarget
|
July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4
Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Organic & Biomolecular Chemistry
|
August 30, 2003
Syntheses and biological evaluation of vinblastine congeners
Martin E Kuehne, William G Bornmann, Istvan Markó, et al.
The International Journal of Biological Markers
|
April 18, 2013
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population
Ye Tian, Jin-le Li, Liang Hao, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
Cell Reports
|
October 5, 2022
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
Xiaojun Yuan, Janith A Seneviratne, Shibei Du, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
Cancer Medicine
|
November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
Janith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 289) with videos related to
Sort By:
Page
of 29
Cancers
|
March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface
Hassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 6, 2020
Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular Rejection
Elizabeth Cho, Joyce K Y Wu, Daniella Cunha Birriel, et al.
Molecular Oncology
|
May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
Belamy B Cheung, Owen Tan, Jessica Koach, et al.
Oncotarget
|
July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4
Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Organic & Biomolecular Chemistry
|
August 30, 2003
Syntheses and biological evaluation of vinblastine congeners
Martin E Kuehne, William G Bornmann, Istvan Markó, et al.
The International Journal of Biological Markers
|
April 18, 2013
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population
Ye Tian, Jin-le Li, Liang Hao, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
Cell Reports
|
October 5, 2022
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
Xiaojun Yuan, Janith A Seneviratne, Shibei Du, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
Cancer Medicine
|
November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
Janith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Page
of 29